Bloomer Tech Company Profile

Background

Overview

Bloomer Tech is a healthcare technology company dedicated to advancing cardiovascular care for women through innovative wearable devices. Founded in 2017 by MIT graduates Alicia Chong Rodriguez and Aceil Halaby, the company addresses the significant gender gap in cardiovascular research and treatment by developing medical-grade sensors integrated into everyday garments. Their flagship product, the Bloomer Tech-Augmented Garment (TAG), is a wearable electrocardiogram device that resembles a regular bra, enabling continuous heart health monitoring in a comfortable and discreet manner.

Mission and Vision

Bloomer Tech's mission is to empower women with real-time insights into their cardiovascular health, facilitating early detection and personalized care. By leveraging advanced textile-based sensors and machine learning algorithms, the company aims to revolutionize heart health monitoring, making it more accessible and tailored to female physiology. Their vision is to close the gender gap in cardiovascular research and treatment, ensuring that women receive care that accurately reflects their unique health needs.

Industry Significance

Cardiovascular disease remains the leading cause of death among women, yet many diagnostic tools and treatments have been predominantly designed based on male-centric data. Bloomer Tech's innovative approach addresses this disparity by providing a solution that is both medically effective and attuned to the daily lives of women, thereby enhancing the accuracy and comfort of heart health monitoring.

Key Strategic Focus

Core Objectives

Gender-Specific Health Monitoring: Develop wearable devices that cater specifically to women's cardiovascular health needs.

Early Detection and Prevention: Enable continuous monitoring to facilitate early identification of heart disease risk factors.

Personalized Healthcare: Provide data-driven insights that support tailored treatment plans for women.

Areas of Specialization

Wearable Medical Devices: Design and manufacture garments embedded with medical-grade sensors for continuous health monitoring.

Digital Biomarkers: Utilize machine learning algorithms to analyze physiological data and generate biomarkers specific to female cardiovascular health.

Key Technologies Utilized

Textile-Based Sensors: Integrate flexible, washable sensors into everyday clothing to collect high-resolution cardiovascular data.

Machine Learning Algorithms: Analyze collected data to identify patterns and generate insights for early detection and personalized care.

Primary Markets Targeted

Women at Risk of Cardiovascular Disease: Provide accessible monitoring solutions for women to manage their heart health proactively.

Healthcare Providers: Offer tools that enhance diagnostic accuracy and patient engagement in cardiovascular care.

Financials and Funding

Funding History

Bloomer Tech has secured a total of $5.2 million in funding over multiple rounds. The most recent funding was a $200,000 grant awarded in May 2025.

Notable Investors

MassVentures: A venture capital firm that led the company's most recent funding round.

Utilization of Capital

The funds have been allocated towards expanding pilot programs, collecting clinical data, and further developing the commercial product and user experience.

Pipeline Development

Key Pipeline Candidates

Bloomer Tech-Augmented Garment (TAG): A wearable electrocardiogram device integrated into a bra, designed for continuous heart health monitoring.

Stages of Development

Clinical Trials: The device is undergoing clinical trials to validate its effectiveness in enhancing heart disease treatment and prevention among women.

Target Conditions

Cardiovascular Disease: Focus on early detection and monitoring of heart disease risk factors specific to women.

Anticipated Milestones

Regulatory Approvals: Seeking necessary approvals to bring the device to market.

Commercial Launch: Plans to launch the product following successful clinical validation.

Technological Platform and Innovation

Proprietary Technologies

Textile-Based Sensors: Medical-grade sensors embedded into everyday garments for continuous health monitoring.

Machine Learning Algorithms: Analyze physiological data to generate digital biomarkers specific to female cardiovascular health.

Significant Scientific Methods

Data Analytics: Utilize advanced analytics to interpret complex physiological data and provide actionable insights.

Wearable Technology Integration: Seamlessly incorporate health-monitoring sensors into daily wearables to enhance user compliance and comfort.

Leadership Team

Alicia Chong Rodriguez – Founder & CEO

Alicia is an engineer and inventor with a background in electronic engineering. She co-founded Bloomer Tech to address the gender gap in cardiovascular research and treatment. Alicia was named a TED Fellow in 2021.

Aceil Halaby – Co-founder & Chief Operations Officer

Aceil co-founded Bloomer Tech alongside Alicia, focusing on the operational aspects of the company to ensure the successful development and deployment of their innovative health-monitoring solutions.

Competitor Profile

Market Insights and Dynamics

The femtech sector, focusing on women's health technologies, has experienced significant growth, with close to $1 billion of funding going into femtech startups in 2019 alone. Forbes predicts that the space is poised to become a $25 billion industry within the next five years.

Competitor Analysis

RedShiftBio: Focuses on biopharmaceuticals with an estimated revenue of $3.6 million and 32 employees.

Cangrade: Specializes in AI-driven talent assessment with an estimated revenue of $3.4 million and 30 employees.

Centaur Labs: Provides AI solutions for medical image annotation with an estimated revenue of $6.9 million and 55 employees.

Strategic Collaborations and Partnerships

Bloomer Tech has engaged in partnerships with leading hospitals in the Boston area to pilot their technology, aiming to collect key clinical data and further develop their commercial product and user experience.

Operational Insights

By integrating health-monitoring sensors into everyday garments, Bloomer Tech differentiates itself from competitors by offering a solution that is both medically effective and attuned to the daily lives of women, thereby enhancing the accuracy and comfort of heart health monitoring.

Strategic Opportunities and Future Directions

Bloomer Tech plans to expand its pilot programs, collect additional clinical data, and further develop its commercial product and user experience. The company is also seeking regulatory approvals to bring its device to market and anticipates launching the product following successful clinical validation.